Searching... please wait. You've got 327 hits!
Acronym | Full Name | Score | Rating | Judge me | Search |
PE | pulmonary embolism | 398 | -1 | good bad |
![]() ![]() |
PE | phosphatidylethanolamine | 184 | 25 | good bad |
![]() ![]() |
PE | phenylephrine | 139 | 7 | good bad |
![]() ![]() |
PE | plasma exchange | 84 | 8 | good bad |
![]() ![]() |
PE | Pseudomonas exotoxin | 49 | 6 | good bad |
![]() ![]() |
PE | polyethylene | 26 | 7 | good bad |
![]() ![]() |
PE | Pseudomonas exotoxin A | 24 | 2 | good bad |
![]() ![]() |
PE | plating efficiency | 18 | 27 | good bad |
![]() ![]() |
PE | phosphatidyl ethanolamine | 16 | 7 | good bad |
![]() ![]() |
PE | preeclampsia | 11 | 26 | good bad |
![]() ![]() |
PE | physical education | 11 | 25 | good bad |
![]() ![]() |
PE | pigment epithelium | 11 | 8 | good bad |
![]() ![]() |
PE | postexposure | 10 | 21 | good bad |
![]() ![]() |
PE | plasma exchanges | 10 | 21 | good bad |
![]() ![]() |
PE | physical examination | 10 | 7 | good bad |
![]() ![]() |
PE | Pericardial effusion | 9 | 25 | good bad |
![]() ![]() |
PE | pulmonary edema | 9 | 21 | good bad |
![]() ![]() |
PE | pigmented epithelial | 9 | 4 | good bad |
![]() ![]() |
PE | plasma extravasation | 8 | 10 | good bad |
![]() ![]() |
PE | pigmented epithelium | 8 | 6 | good bad |
![]() ![]() |
PE | pulmonary emphysema | 6 | 27 | good bad |
![]() ![]() |
PE | Pleural effusion | 6 | 5 | good bad |
![]() ![]() |
PE | Pleural effusion | 6 | 5 | good bad |
![]() ![]() |
PE | physical exercise | 5 | 26 | good bad |
![]() ![]() |
PE | proenkephalin | 5 | 8 | good bad |
![]() ![]() |
PE | pigmented ciliary epithelial | 5 | 8 | good bad |
![]() ![]() |
PE | parietal endoderm | 5 | 7 | good bad |
![]() ![]() |
PE | persistent estrus | 5 | 7 | good bad |
![]() ![]() |
PE | phosphorylethanolamine | 5 | 3 | good bad |
![]() ![]() |
PE | phosphatidylserine (PS) and phosphatidylethanolamine | 4 | 21 | good bad |
![]() ![]() |
PE | pleural effusions | 4 | 19 | good bad |
![]() ![]() |
PE | plating efficiencies | 4 | 13 | good bad |
![]() ![]() |
PE | penile erection | 4 | 8 | good bad |
![]() ![]() |
PE | prolonged exposure in vivo | 4 | 7 | good bad |
![]() ![]() |
PE | penile erections | 4 | 5 | good bad |
![]() ![]() |
PE | phosphatidylethanolamines | 4 | -1 | good bad |
![]() ![]() |
PE | Pregnenolone | 3 | 28 | good bad |
![]() ![]() |
PE | progressive encephalopathy | 3 | 28 | good bad |
![]() ![]() |
PE | periventricular nucleus | 3 | 24 | good bad |
![]() ![]() |
PE | falciparum-parasitized erythrocytes | 3 | 9 | good bad |
![]() ![]() |
PE | pharyngoesophageal | 3 | 9 | good bad |
![]() ![]() |
PE | post-exposure | 3 | 7 | good bad |
![]() ![]() |
PE | proliferative enteritis | 3 | 7 | good bad |
![]() ![]() |
PE | pressure equalization | 3 | 5 | good bad |
![]() ![]() |
PE | pre-eclampsia | 3 | 5 | good bad |
![]() ![]() |
PE | parasitized erythrocytes | 3 | 4 | good bad |
![]() ![]() |
PE | phosphoethanolamine | 3 | 3 | good bad |
![]() ![]() |
PE | phacoemulsification | 3 | 2 | good bad |
![]() ![]() |
PE | promoter | 3 | 2 | good bad |
![]() ![]() |
PE | prolonged exposure | 3 | -1 | good bad |
![]() ![]() |
PE | pulmonary thromboembolism | 2 | 31 | good bad |
![]() ![]() |
PE | preeclamptic | 2 | 22 | good bad |
![]() ![]() |
PE | protective efficacy | 2 | 16 | good bad |
![]() ![]() |
PE | beta-phenylethylamine | 2 | 12 | good bad |
![]() ![]() |
PE | pulmonary embolization | 2 | 10 | good bad |
![]() ![]() |
PE | phenylephrine hydrochloride | 2 | 9 | good bad |
![]() ![]() |
PE | push enteroscopy | 2 | 9 | good bad |
![]() ![]() |
PE | perphenazine enanthate | 2 | 9 | good bad |
![]() ![]() |
PE | physical exercises | 2 | 9 | good bad |
![]() ![]() |
PE | phosphoglycerides | 2 | 8 | good bad |
![]() ![]() |
PE | proximal element | 2 | 8 | good bad |
![]() ![]() |
PE | protein extravasation | 2 | 7 | good bad |
![]() ![]() |
PE | pulmonary eosinophilia | 2 | 7 | good bad |
![]() ![]() |
PE | pineal extract | 2 | 7 | good bad |
![]() ![]() |
PE | performance error | 2 | 6 | good bad |
![]() ![]() |
PE | Precedence Effect | 2 | 6 | good bad |
![]() ![]() |
PE | Polyelectrolyte | 2 | 6 | good bad |
![]() ![]() |
PE | post exposure | 2 | 5 | good bad |
![]() ![]() |
PE | polychromatic erythrocytes (MPE) among polychromatic erythrocytes | 2 | 5 | good bad |
![]() ![]() |
PE | poor | 2 | 5 | good bad |
![]() ![]() |
PE | platelet extract | 2 | 4 | good bad |
![]() ![]() |
PE | psoriasis erythrodermica | 2 | 4 | good bad |
![]() ![]() |
PE | prolyl endopeptidase | 2 | 4 | good bad |
![]() ![]() |
PE | parallel elastic | 2 | 4 | good bad |
![]() ![]() |
PE | parasitized erythrocyte | 2 | 4 | good bad |
![]() ![]() |
PE | cisplatin-etoposide | 2 | 4 | good bad |
![]() ![]() |
PE | pseudoexfoliation syndrome | 2 | 3 | good bad |
![]() ![]() |
PE | PEG-diisocyanate treated surfaces experienced 96% | 2 | 3 | good bad |
![]() ![]() |
PE | pars externa | 2 | 3 | good bad |
![]() ![]() |
PE | pearl | 2 | 3 | good bad |
![]() ![]() |
PE | propylene oxide | 2 | 2 | good bad |
![]() ![]() |
PE | Polyurethane (PU) and polyethylene | 2 | -2 | good bad |
![]() ![]() |
PE | previous experience comparing cisplatin/etoposide | 1 | 32 | good bad |
![]() ![]() |
PE | peritoneal effluent | 1 | 30 | good bad |
![]() ![]() |
PE | palpation examination | 1 | 29 | good bad |
![]() ![]() |
PE | peripheral blood eosinophilia | 1 | 29 | good bad |
![]() ![]() |
PE | polyethyleneglycol(PEG)-phosphatidylethanolamine | 1 | 28 | good bad |
![]() ![]() |
PE | pleural empyema | 1 | 28 | good bad |
![]() ![]() |
PE | pemphigus erythematosus | 1 | 27 | good bad |
![]() ![]() |
PE | paraffin embedded | 1 | 26 | good bad |
![]() ![]() |
PE | (R)-phycoerythrin | 1 | 26 | good bad |
![]() ![]() |
PE | dioleoyl-phosphatidylcholine (PC) and dioleoyl-phosphatidylethanolamine | 1 | 26 | good bad |
![]() ![]() |
PE | primary extranodal | 1 | 26 | good bad |
![]() ![]() |
PE | point estimates | 1 | 26 | good bad |
![]() ![]() |
PE | pure ethanol | 1 | 25 | good bad |
![]() ![]() |
PE | phosphatidyl ethanolamines | 1 | 25 | good bad |
![]() ![]() |
PE | parabolic wave equation | 1 | 25 | good bad |
![]() ![]() |
PE | production of erythrocytes | 1 | 25 | good bad |
![]() ![]() |
PE | pregnancy-induced hypertension (PIH) and preeclampsia | 1 | 25 | good bad |
![]() ![]() |
PE | prostate epithelial | 1 | 25 | good bad |
![]() ![]() |
PE | physician's extender | 1 | 24 | good bad |
![]() ![]() |
PE | Periapical exudates | 1 | 24 | good bad |
![]() ![]() |
PE | plaque enlargement | 1 | 24 | good bad |
![]() ![]() |
PE | polychromatic erythroblasts | 1 | 24 | good bad |
![]() ![]() |
PE | 5-amino-1-pentanol | 1 | 24 | good bad |
![]() ![]() |
PE | cis-platin/etoposide | 1 | 24 | good bad |
![]() ![]() |
PE | propofol on phenylephrine | 1 | 23 | good bad |
![]() ![]() |
PE | phosphatidylcholine (PC) and ethanolamine | 1 | 23 | good bad |
![]() ![]() |
PE | preceded by pectin methylesterase | 1 | 23 | good bad |
![]() ![]() |
PE | polyethers | 1 | 23 | good bad |
![]() ![]() |
PE | polyethyleneglycol (PEG)-phosphatidylethanolamine | 1 | 22 | good bad |
![]() ![]() |
PE | proliferative endometria | 1 | 22 | good bad |
![]() ![]() |
PE | presence of phosphatidylethanolamine | 1 | 22 | good bad |
![]() ![]() |
PE | pigeon erythrocytes | 1 | 21 | good bad |
![]() ![]() |
PE | person equivalent | 1 | 21 | good bad |
![]() ![]() |
PE | primers in an automated 377 sequencer | 1 | 21 | good bad |
![]() ![]() |
PE | persistent-estrous | 1 | 20 | good bad |
![]() ![]() |
PE | polarizable electropole | 1 | 20 | good bad |
![]() ![]() |
PE | proestrus | 1 | 20 | good bad |
![]() ![]() |
PE | Phthalate esters | 1 | 19 | good bad |
![]() ![]() |
PE | penile enlargement | 1 | 19 | good bad |
![]() ![]() |
PE | probe-earmold | 1 | 19 | good bad |
![]() ![]() |
PE | Proportionate expansion | 1 | 18 | good bad |
![]() ![]() |
PE | phenelzine (PLZ) or of beta-phenylethylamine | 1 | 18 | good bad |
![]() ![]() |
PE | platinum + epirubicin | 1 | 18 | good bad |
![]() ![]() |
PE | phosphoglyceride fraction | 1 | 17 | good bad |
![]() ![]() |
PE | patients with suspected pulmonary thromboembolism | 1 | 16 | good bad |
![]() ![]() |
PE | placentome to phenylephrine | 1 | 16 | good bad |
![]() ![]() |
PE | paralytic esotropia | 1 | 15 | good bad |
![]() ![]() |
PE | patients with failed Kasai portoenterostomy | 1 | 14 | good bad |
![]() ![]() |
PE | phenol | 1 | 14 | good bad |
![]() ![]() |
PE | posthypoxic encephalopathies | 1 | 13 | good bad |
![]() ![]() |
PE | plasmaexchange | 1 | 13 | good bad |
![]() ![]() |
PE | propidium iodide (PI) and R-phycoerythrin | 1 | 12 | good bad |
![]() ![]() |
PE | PMN were labeled with phycoerythrin-E | 1 | 12 | good bad |
![]() ![]() |
PE | percentage of platelets binding phycoerythrin | 1 | 11 | good bad |
![]() ![]() |
PE | auristatin-phenethylamine | 1 | 11 | good bad |
![]() ![]() |
PE | phospholipid phosphatidylethanolamine | 1 | 10 | good bad |
![]() ![]() |
PE | PIH or preeclampsia | 1 | 10 | good bad |
![]() ![]() |
PE | placental extract | 1 | 10 | good bad |
![]() ![]() |
PE | patients and patients with pre-eclampsia | 1 | 10 | good bad |
![]() ![]() |
PE | Peak enhancement | 1 | 10 | good bad |
![]() ![]() |
PE | Parodi endograft | 1 | 10 | good bad |
![]() ![]() |
PE | phase encoding | 1 | 9 | good bad |
![]() ![]() |
PE | pulmonary | 1 | 9 | good bad |
![]() ![]() |
PE | pre eclamptic | 1 | 9 | good bad |
![]() ![]() |
PE | polyethylene terephthalate (PET) or polyester | 1 | 9 | good bad |
![]() ![]() |
PE | Plasma-exchange | 1 | 9 | good bad |
![]() ![]() |
PE | phosphatidyleth-anolamine | 1 | 9 | good bad |
![]() ![]() |
PE | paraffin-embedded | 1 | 9 | good bad |
![]() ![]() |
PE | population equivalent | 1 | 9 | good bad |
![]() ![]() |
PE | mildest--premature ejaculation | 1 | 9 | good bad |
![]() ![]() |
PE | proportional error | 1 | 9 | good bad |
![]() ![]() |
PE | phosphate contents | 1 | 9 | good bad |
![]() ![]() |
PE | periventricular preoptic nucleus | 1 | 9 | good bad |
![]() ![]() |
PE | phase of the unsaturated dioleoylphosphatidylethanolamine | 1 | 9 | good bad |
![]() ![]() |
PE | early | 1 | 9 | good bad |
![]() ![]() |
PE | pulmonary endocrine | 1 | 9 | good bad |
![]() ![]() |
PE | phycobiliproteins phycoerythrin | 1 | 9 | good bad |
![]() ![]() |
PE | phospholipids phosphatidylcholine (PC) and phosphatidylethanolamine | 1 | 9 | good bad |
![]() ![]() |
PE | probability equivalence approach | 1 | 9 | good bad |
![]() ![]() |
PE | preexposed | 1 | 9 | good bad |
![]() ![]() |
PE | permeability coefficients | 1 | 8 | good bad |
![]() ![]() |
PE | 2-diacyl-sn-glycero-3-phosphoethanolamine | 1 | 8 | good bad |
![]() ![]() |
PE | pars esophageal | 1 | 8 | good bad |
![]() ![]() |
PE | packed erythrocytes | 1 | 8 | good bad |
![]() ![]() |
PE | Platinum and Etoposide | 1 | 8 | good bad |
![]() ![]() |
PE | pectinesterase | 1 | 8 | good bad |
![]() ![]() |
PE | placebo+exposure | 1 | 8 | good bad |
![]() ![]() |
PE | Proton enhanced | 1 | 8 | good bad |
![]() ![]() |
PE | Pseudomonas aeruginosa elastase | 1 | 8 | good bad |
![]() ![]() |
PE | partial (70%) hepatectomy on phosphatidylethanolamine | 1 | 8 | good bad |
![]() ![]() |
PE | plasma glucosylceramide (GlcCer) or phosphatidylethanolamine | 1 | 8 | good bad |
![]() ![]() |
PE | probability of exclusion | 1 | 8 | good bad |
![]() ![]() |
PE | program evaluation | 1 | 8 | good bad |
![]() ![]() |
PE | anti-phosphatidylethanolamine | 1 | 8 | good bad |
![]() ![]() |
PE | pregnancy and preeclampsia | 1 | 8 | good bad |
![]() ![]() |
PE | primarily ethanolamine | 1 | 7 | good bad |
![]() ![]() |
PE | prostaglandin E-1 | 1 | 7 | good bad |
![]() ![]() |
PE | polyethylene terephthalate (PET) and polyethylene | 1 | 7 | good bad |
![]() ![]() |
PE | polyethene | 1 | 7 | good bad |
![]() ![]() |
PE | patients with IBD using phycoerythrin | 1 | 7 | good bad |
![]() ![]() |
PE | Peclet number | 1 | 7 | good bad |
![]() ![]() |
PE | probe fluo-3 and using R-phycoerythrin | 1 | 7 | good bad |
![]() ![]() |
PE | PC to phosphatidylethanolamine | 1 | 7 | good bad |
![]() ![]() |
PE | preferentially hydrolyzes phosphatidylethanolamine | 1 | 7 | good bad |
![]() ![]() |
PE | portal circulations | 1 | 7 | good bad |
![]() ![]() |
PE | propionyl esterase | 1 | 7 | good bad |
![]() ![]() |
PE | properties of polyethylene | 1 | 7 | good bad |
![]() ![]() |
PE | primordial epithelium | 1 | 7 | good bad |
![]() ![]() |
PE | phorbol ester | 1 | 7 | good bad |
![]() ![]() |
PE | pseudoexfoliation | 1 | 7 | good bad |
![]() ![]() |
PE | plasmalogens (EP) and phosphatidylethanolamine | 1 | 7 | good bad |
![]() ![]() |
PE | plasmid DNA vaccine | 1 | 7 | good bad |
![]() ![]() |
PE | pulmonary edema (HAPE) from pulmonary embolism | 1 | 7 | good bad |
![]() ![]() |
PE | primary clarifier effluent | 1 | 7 | good bad |
![]() ![]() |
PE | phosphatidy glycerols (PG) and phosphatidylethanolamine | 1 | 7 | good bad |
![]() ![]() |
PE | phosphati-dylethanolamine | 1 | 7 | good bad |
![]() ![]() |
PE | Physical Evaluation | 1 | 7 | good bad |
![]() ![]() |
PE | ORAC | 1 | 7 | good bad |
![]() ![]() |
PE | pulse energy | 1 | 6 | good bad |
![]() ![]() |
PE | R-phycoerythrin | 1 | 6 | good bad |
![]() ![]() |
PE | precisternal elements | 1 | 6 | good bad |
![]() ![]() |
PE | primer extension | 1 | 6 | good bad |
![]() ![]() |
PE | Epinephrine | 1 | 6 | good bad |
![]() ![]() |
PE | phospholipid methylation which converts phosphatidylethanolmine | 1 | 6 | good bad |
![]() ![]() |
PE | physician extenders | 1 | 6 | good bad |
![]() ![]() |
PE | prediction error | 1 | 6 | good bad |
![]() ![]() |
PE | peptide E | 1 | 6 | good bad |
![]() ![]() |
PE | Péclet number | 1 | 6 | good bad |
![]() ![]() |
PE | preliminary exercise | 1 | 6 | good bad |
![]() ![]() |
PE | pigmented ciliary epithelial cells | 1 | 6 | good bad |
![]() ![]() |
PE | processing elements | 1 | 6 | good bad |
![]() ![]() |
PE | phospholipids were phosphatidylethanolamine | 1 | 6 | good bad |
![]() ![]() |
PE | plasma exudation | 1 | 6 | good bad |
![]() ![]() |
PE | poorly on phosphatidylethanolamine | 1 | 6 | good bad |
![]() ![]() |
PE | pancreatic enzymes | 1 | 6 | good bad |
![]() ![]() |
PE | proteoglycan-degrading enzymes | 1 | 6 | good bad |
![]() ![]() |
PE | pore's radius | 1 | 6 | good bad |
![]() ![]() |
PE | phosphatidylcholine (PC) phosphatidylethanolamine | 1 | 6 | good bad |
![]() ![]() |
PE | Portoenterostomy | 1 | 6 | good bad |
![]() ![]() |
PE | prostaglandin E1 | 1 | 6 | good bad |
![]() ![]() |
PE | N-acyl-phosphatidylethanolamine | 1 | 6 | good bad |
![]() ![]() |
PE | parasitized (Plasmodium berghei) erythrocytes | 1 | 6 | good bad |
![]() ![]() |
PE | phosphatidylcholine (PC)/phosphatidylethanolamine | 1 | 6 | good bad |
![]() ![]() |
PE | phosphatidylcholines (PC) or phosphatidylethanolamines | 1 | 6 | good bad |
![]() ![]() |
PE | propylene gas | 1 | 6 | good bad |
![]() ![]() |
PE | posterior ectosylvian | 1 | 6 | good bad |
![]() ![]() |
PE | protected environment | 1 | 5 | good bad |
![]() ![]() |
PE | Proportions of phosphatidylethanolamine | 1 | 5 | good bad |
![]() ![]() |
PE | anti-CD-14-phycoerythrin | 1 | 5 | good bad |
![]() ![]() |
PE | pure erythrocytosis | 1 | 5 | good bad |
![]() ![]() |
PE | [14C]arachidonoylphosphatidylethanolamine | 1 | 5 | good bad |
![]() ![]() |
PE | priming exercise | 1 | 5 | good bad |
![]() ![]() |
PE | processed vinyl resins and polyethylene | 1 | 5 | good bad |
![]() ![]() |
PE | prominent ears | 1 | 5 | good bad |
![]() ![]() |
PE | d-pseudoephedrine | 1 | 5 | good bad |
![]() ![]() |
PE | dioleoylphosphatidylethanolamine | 1 | 5 | good bad |
![]() ![]() |
PE | proportion of errors | 1 | 5 | good bad |
![]() ![]() |
PE | Gd-DTPA-phosphatidylethanolamine | 1 | 5 | good bad |
![]() ![]() |
PE | pathway was pregnenolone | 1 | 5 | good bad |
![]() ![]() |
PE | promotes the methylation of phosphatidylethanolamine | 1 | 5 | good bad |
![]() ![]() |
PE | pasteurization effect | 1 | 5 | good bad |
![]() ![]() |
PE | postembolization | 1 | 5 | good bad |
![]() ![]() |
PE | phenylethylamine | 1 | 5 | good bad |
![]() ![]() |
PE | PERA/Ei | 1 | 5 | good bad |
![]() ![]() |
PE | polyhedron envelope | 1 | 5 | good bad |
![]() ![]() |
PE | pleiotropic effects | 1 | 5 | good bad |
![]() ![]() |
PE | Positive expectancies | 1 | 5 | good bad |
![]() ![]() |
PE | PEG-filgrastim, | 1 | 5 | good bad |
![]() ![]() |
PE | possible pathogenetic factor of preeclampsia | 1 | 5 | good bad |
![]() ![]() |
PE | phospholipids including phosphatidylethanolamine | 1 | 5 | good bad |
![]() ![]() |
PE | pituitary extract | 1 | 5 | good bad |
![]() ![]() |
PE | pre-mixed fluorescein isothiocyanate (FITC) and R-phycoerythrin | 1 | 5 | good bad |
![]() ![]() |
PE | pigmented ciliary epithelium | 1 | 5 | good bad |
![]() ![]() |
PE | pectin | 1 | 5 | good bad |
![]() ![]() |
PE | physical exam | 1 | 5 | good bad |
![]() ![]() |
PE | pericardial effusions | 1 | 5 | good bad |
![]() ![]() |
PE | persistent type-II endoleaks | 1 | 4 | good bad |
![]() ![]() |
PE | Proopiomelanocortin (POMC) and proenkephalin | 1 | 4 | good bad |
![]() ![]() |
PE | peritumoral edema | 1 | 4 | good bad |
![]() ![]() |
PE | pallium externum | 1 | 4 | good bad |
![]() ![]() |
PE | polyclonal antibody biotinylated ELISA | 1 | 4 | good bad |
![]() ![]() |
PE | Phytoestrogens | 1 | 4 | good bad |
![]() ![]() |
PE | phosphorous esters | 1 | 4 | good bad |
![]() ![]() |
PE | phospholipids phosphatidylethanolamine | 1 | 4 | good bad |
![]() ![]() |
PE | pinealectomy | 1 | 4 | good bad |
![]() ![]() |
PE | plasma estrone | 1 | 4 | good bad |
![]() ![]() |
PE | exclamans | 1 | 4 | good bad |
![]() ![]() |
PE | phosphate ester | 1 | 4 | good bad |
![]() ![]() |
PE | proteinuria | 1 | 4 | good bad |
![]() ![]() |
PE | poly(ethylene) | 1 | 4 | good bad |
![]() ![]() |
PE | peritoneal cavity | 1 | 4 | good bad |
![]() ![]() |
PE | predominantly epithelioid | 1 | 4 | good bad |
![]() ![]() |
PE | PC and phosphatidylethanolamine | 1 | 4 | good bad |
![]() ![]() |
PE | primarily incorporated into phosphatidylethanolamine | 1 | 4 | good bad |
![]() ![]() |
PE | prior exercise | 1 | 4 | good bad |
![]() ![]() |
PE | passive extensibility | 1 | 4 | good bad |
![]() ![]() |
PE | Phosphorothioate (PS)-capped phosphodiester | 1 | 3 | good bad |
![]() ![]() |
PE | phenylepherine | 1 | 3 | good bad |
![]() ![]() |
PE | pectus excavatum | 1 | 3 | good bad |
![]() ![]() |
PE | plasma norepinephrine (PNE) or epinephrine | 1 | 3 | good bad |
![]() ![]() |
PE | extravidin-R-phycoerythrin | 1 | 3 | good bad |
![]() ![]() |
PE | phospholipase D hydrolyses phosphatidylethanolamine | 1 | 3 | good bad |
![]() ![]() |
PE | Pseudomonas elastase | 1 | 3 | good bad |
![]() ![]() |
PE | yoelii-parasitized erythrocytes | 1 | 3 | good bad |
![]() ![]() |
PE | peak-equivalent | 1 | 3 | good bad |
![]() ![]() |
PE | prematurity effect | 1 | 3 | good bad |
![]() ![]() |
PE | pulmonary embolisms | 1 | 3 | good bad |
![]() ![]() |
PE | pressure | 1 | 3 | good bad |
![]() ![]() |
PE | pregnancy edema | 1 | 3 | good bad |
![]() ![]() |
PE | positive by day 14 postexposure | 1 | 3 | good bad |
![]() ![]() |
PE | potassium (K+) or phenylephrine | 1 | 3 | good bad |
![]() ![]() |
PE | pertioneal exudate | 1 | 3 | good bad |
![]() ![]() |
PE | patients' archived paraffin-embedded | 1 | 3 | good bad |
![]() ![]() |
PE | pre-exposed | 1 | 3 | good bad |
![]() ![]() |
PE | potato extracts | 1 | 3 | good bad |
![]() ![]() |
PE | primary treatment effluent water | 1 | 2 | good bad |
![]() ![]() |
PE | projection encoding | 1 | 2 | good bad |
![]() ![]() |
PE | diacyl-phosphatidylethanolamine | 1 | 2 | good bad |
![]() ![]() |
PE | phospholipids labeled were phosphatidylethanolamine | 1 | 2 | good bad |
![]() ![]() |
PE | pulmonary eosinophiles | 1 | 2 | good bad |
![]() ![]() |
PE | perimeter | 1 | 2 | good bad |
![]() ![]() |
PE | Prompt commencement of plasma-exchange | 1 | 2 | good bad |
![]() ![]() |
PE | 1-palmitoyl-2-stearoyl glycerophosphoethanolamine | 1 | 2 | good bad |
![]() ![]() |
PE | peritonitis | 1 | 2 | good bad |
![]() ![]() |
PE | product and pro-enkephalin | 1 | 2 | good bad |
![]() ![]() |
PE | Phosphatidylinositolmannosides and phosphatidylethanolamine | 1 | 2 | good bad |
![]() ![]() |
PE | pregnancies complicated by severe preeclampsia | 1 | 2 | good bad |
![]() ![]() |
PE | partial pressure | 1 | 2 | good bad |
![]() ![]() |
PE | PH are pulmonary thromboemboli | 1 | 2 | good bad |
![]() ![]() |
PE | plus etoposide | 1 | 2 | good bad |
![]() ![]() |
PE | preventive effect on pulmonary edema | 1 | 1 | good bad |
![]() ![]() |
PE | phophatidylethanolamine | 1 | 1 | good bad |
![]() ![]() |
PE | Penne | 1 | 1 | good bad |
![]() ![]() |
PE | pyroglutamate | 1 | 0 | good bad |
![]() ![]() |
PE | pyroglutamic | 1 | 0 | good bad |
![]() ![]() |
PE | phycocyanin (PC) and phycoerythrin | 1 | 0 | good bad |
![]() ![]() |
PE | phospholipids combined with phosphatidylethanolamine | 1 | 0 | good bad |
![]() ![]() |
PE | provided they contained phosphatidylethanolamine | 1 | 0 | good bad |
![]() ![]() |
PE | periapical exudate | 1 | 0 | good bad |
![]() ![]() |
PE | proliferative effect | 1 | 0 | good bad |
![]() ![]() |
PE | probability of sire exclusion | 1 | -1 | good bad |
![]() ![]() |
PE | primitive endoderm | 1 | -2 | good bad |
![]() ![]() |
PE | physical examination by trained personnel | 1 | -2 | good bad |
![]() ![]() |
PE | principally with phosphatidylethanolamine | 1 | -2 | good bad |
![]() ![]() |
PE | phosphatidylethanolamino | 1 | -2 | good bad |
![]() ![]() |
|
Text2Knowledge ... Yong Huang
2002
|